Gastroenterology and Hepatology Peer Reviewers

Manal F Abdelmalek, MD, MPH

Associate Professor of Medicine

Duke University Medical Center

Disclosure: Grant/Research/Clinical Trial Support: Gilead [NASH (Simtuzumab, GS-4997)]; NGM Biopharmaceuticals [NASH (FGF-19)]; TaiwanJ [NASH (JKB-121)]; Tobira [NASH (Cenicriviroc mesylate)]; Immuron [NASH (Imm-124E)]; Intercept [NASH (Obeticholic acid)]; Bristol-Myers Squibb [NASH (FGF-21)]; Conatus [NASH (Emricasan)]; Madrigal [NASH (MGL-3196)]; Galmed [NASH (Aramchol)]; Genfit [NASH (Elafibranor)]. Speaker's Bureau: Alexiion [LAL deficiency]. Consultant/Advisory Boards: Islet Science; TaiwanJ; Immuron; Madrigal.

Thomas L Abell, MD

AGA Peer Reviewer

Arthur M Shoen MD Chair in Gastroenterology

University of Louisville

Disclosure: Grant/Research/Clinical Trial Support: NIH [Grants]; Medtronic [Device study (New GES device study)]; Rhythm [Drug study (Investigational drug)]; Theravance [Drug study (Investigational drug)]. Speaker's Bureau: Medtronic [Gastroparesis (GES device)]. Consultant/Advisory Boards: Medtronic [Obesity (New GES device)]. Patent Holder: ADEPT-GI [Obesity and nausea/vomiting]. Equity Ownership/Stock Options: ADEPT-GI [Founder]. Other Financial Interest: MedStudy [GI section editor].

Douglas G Adler, MD, FACG, AGAF, FASGE

Professor of Medicine

University of Utah School of Medicine

Disclosure: Consultant/Advisory Boards: Boston Scientific; Merit Pharmaceuticals; Abbvie [Endoscopy (Pancreatic Treatments)]; Olypmus.

Nuzhat A Ahmad, MD

Assistant Professor of Medicine

University of Pennsylvania School of Medicine

Disclosure: Nothing to disclose

Johan S Bakken, MD, PhD

Associate Professor, School of Medicine

University of Minnesota, Duluth

Disclosure: Nothing to disclose

Stephen J Bickston, MD

Professor of Internal Medicine

Virginia Commonwealth University Health Center

Disclosure: Nothing to disclose

Herbert L Bonkovsky, MD

Adjunct Professor, University of North Carolina

Professor, University of Connecticut

Disclosure: Grant/Research/Clinical Trial Support: Clinuvel [Porphyria (Afamalanotide)]; Alnylam Pharma; Gilead Sciences [PCT HCV]; Recordati; Mitsubishi-Tanabe [Porphyria (hematin)]. Consultant/Advisory Boards: Alnylam Pharma; Recordati; Mitsubishi-Tanabe [Porphyria (hematin)].

Robert S Brown, Jr, MD, MPH

Section Editor — Liver Transplantation

Vice Chair, Transitions of Care, Department of Medicine

Interim Chief, Division of Gastroenterology and Hepatology

Weill Cornell Medical College

Professor of Clinical Medicine, Columbia University College of Physicians & Surgeons

Disclosure: Grant/Research/Clinical Trial Support: Gilead; Bristol-Myers Squibb; Janssen; AbbVie; Merck; [Hepatitis C, ALF (various direct-acting agents for HCV, bioartificial liver devices)]. Consultant/Advisory Boards: Gilead; Bristol-Myers Squibb; Janssen; AbbVie; Merck; Vital Therapies [Hepatitis B and C, ALF (various direct-acting agents for HCV, bioartificial liver devices)].

William Brugge, MD

Professor of Medicine

Harvard Medical School

Disclosure: Consultant/Advisory Boards: Consultant [Boston Scientific].

Donald O Castell, MD

AGA Peer Reviewer

Professor of Medicine

Director, Esophageal Disorders Program

Medical University of South Carolina

Disclosure: Nothing to disclose

David Cave, MD, PhD

Professor of Medicine

University of Massachusetts Medical Center

Disclosure: Grant/Research/Clinical Trial Support: Olympus [Video capsule endoscopy (clinical trial)]: Olympus [Enteroscopy (Enteroscope)]; Celgene [Clinical trial]. Speaker’s Bureau: Medtronics [Course director (Video capsule endoscopy)]. Consultant/Advisory Boards: Boston Scientific [Device development].

Daniel C Chung, MD

Associate Professor of Medicine

Harvard Medical School

Disclosure: Nothing to disclose

Felipe B Collares, MD

Instructor in Radiology

Harvard Medical School

Disclosure: Nothing to disclose

Robert M Craig, MD

Emeritus Professor

Northwestern University

Feinberg School of Medicine

Disclosure: Nothing to disclose

Carmen Cuffari, MD

Associate Professor of Pediatrics

The Johns Hopkins University School of Medicine

Disclosure: Grant/Research/Clinical Trial Support: Shire [Inflammatory bowel disease (Mesamaline)]. Speaker's Bureau: Pometheus Labs [Inflammatory bowel disease (monitoring test)]; Abbvie [IBD (adalimumab)].

Brian G Czito, MD

Associate Professor

Duke University Medical Center

Disclosure: Nothing to disclose

Roberto de Cleva, MD, PhD

University of Sao Paulo Medical School

Sao Paulo, Brazil

Disclosure: Nothing to disclose

Ronnie Fass, MD

AGA Peer Reviewer

Professor of Medicine

Case Western Reserve University

Disclosure: Grant/Research/Clinical Trial Support: Ironwood [GERD (investigational]; Evoke [Gastroparesis (investigational)]. Speaker's Bureau: Takeda [GERD (dexlansoprazole)]; AstraZeneca [GERD (esomeprazole magnesium)]; Dr. Reddy (GERD); Mederi (GERD). Consultant/Advisory Boards: Mederi [GERD (radiofrequency endoscopy catheter)]; Pfizer [GERD (esomeprazole magnesium)]; Torax [GERD (transoral incisionless fundoplication )]; Medtronic [Esophageal motility (esophageal pH monitoring, high resolution esophageal manometry)]; IM Health Science [IBS]; Synthetic Biologics [IBS]; Allergan [IBS]; Ethicon [GERD].

Syed M Abbas Fehmi, MD, MSc

Assistant Professor, Division of Gastroenterology

University of California, San Diego

Disclosure: Nothing to disclose

M Brian Fennerty, MD

Professor of Medicine

Division of Gastroenterology and Hepatology

Oregon Health and Science University

Disclosure: Nothing to disclose

Phillip R Fleshner, MD, FACS

Division of Colorectal Surgery

Cedars-Sinai Medical Center

Disclosure: Nothing to disclose

Christopher E Forsmark, MD

Professor of Medicine and Chief

Division of Gastroenterology, Hepatology, and Nutrition

University of Florida

Disclosure: Grant/Research/Clinical Trial Support: NIH Research Support. Consultant/Advisory Boards: Boehringer-Ingelheim - Consultant.

Lawrence S Friedman, MD

Section Editor — General Gastroenterology

Professor of Medicine

Harvard Medical School

Tufts University School of Medicine

Disclosure: Consultant/Advisory Boards: Consultant, FDA (Antimicrobial Drugs Advisory Committee); Trustee, Newton-Wellesley Hospital (through June 2017). Employment: Boston Health Care for the Homeless. Other Financial Interest: Elsevier [Gastroenterology (Royalties from textbooks)]; McGraw-Hill [Gastroenterology (Royalties from textbooks)]; Wiley [Gastroenterology (Royalties from textbooks)]; American Society for Gastrointestinal Endoscopy [Gastroenterology and hepatology (Honorarium as newsletter editor)].

Glenn T Furuta, MD

Professor of Pediatrics

University of Colorado School of Medicine

Disclosure: Grant/Research/Clinical Trial Support: Morphotek [Basic research]; Nutricia [clinical research]. Consultant/Advisory Boards: Shire [Consultant]. Patent Holder: Esophageal String test [Eosinophilic esophagitis (Esophageal String Test)]. Equity Ownership/Stock Options: Founder-EnterotTrack [Eosinophilic esophagitis (Esophageal String Test)].

Gregory G Ginsberg, MD

Professor of Medicine

University of Pennsylvania School of Medicine

Disclosure: Nothing to disclose

Joel E Goldberg, MD, FACS

Assistant Professor of Surgery

Harvard Medical School

Disclosure: Nothing to disclose

Fredric D Gordon, MD

Associate Professor of Medicine

Tufts University Medical School

Disclosure: Grant/Research/Clinical Trial Support: Intercept Pharmaceuticals [Primary Biliary Cirrhosis (NASH)(obeticholic acid)]. Consultant/Advisory Boards: Intercept Pharmaceuticals [Primary Biliary Cirrhosis (obeticholic acid)].

Stuart C Gordon, MD, FACP, FACG, AGAF

Clinical Professor of Medicine

Wayne State University School of Medicine

Disclosure: Grant/Research/Clinical Trial Support: AbbVie [Hepatitis C (Paritaprevir/Ombitasvir/Dasabuvir, Glecaprevir/Pibrentasvir)]; Bristol-Myers Squibb [Hepatitis C (Daclatasvir)]; Conatus Pharmaceuticals [Nonalcoholic Steatohepatitis (Emricasan)]; Conatus Pharmaceuticals [Liver Cirrhosis (Emricasan)]; CymaBay Therapeutics, Inc. [Primary Biliary Cholangitis (MBX-8025)]; Eisai Inc. [Thrombocytopenia (Avatrombopag)]; Exalenz Bioscience Ltd [Liver Disease, Hepatic Decompensation (13C Methacetin Breath Test)]; Galectin Therapeutics Inc [Nonalcoholic Steatohepatitis (GR-MD-02)]; Gilead Sciences [Hepatitis B (Tenofovir/Tenofovir Alafenamide, GS-9620)]; Gilead Sciences [Hepatitis C (Ledipasvir/Sofosbuvir, Sofosbuvir/Velpatasvir/Voxilaprevir)]; Genfit [Nonalcoholic Steatohepatitis (Elafibranor)]; Intercept Pharmaceuticals [Nonalcoholic Steatohepatitis (Obeticholic Acid)]; Intercept Pharmaceuticals [Primary Biliary Cirrhosis (Obeticholic Acid)]; Intercept Pharmaceuticals, Inc. [Primary Sclerosing Cholangitis (Obeticholic Acid)]; Shionogi [Thrombocytopenia (Lusutrombopag)]; Shire Human Genetic Therapies, Inc. [Nonalcoholic Steatohepatitis (Volixibat potassium, SHP626)]; Merck [Hepatitis C (elbasvir/grazoprevir, Uprifosbuvir, Ruzasvir)]; NGM Biopharmaceuticals, Inc. [Primary Sclerosing Cholangitis (NGM282)] Consultant/Advisory Boards: AbbVie [Hepatitis C (Paritaprevir/Ombitasvir/Dasabuvir, Glecaprevir/Pibrentasvir)]; CVS Caremark [Viral Hepatitis and Nonalcoholic Fatty Liver Disease (Various Antiviral Agents)]; Gilead Sciences [Hepatitis B (Tenofovir/Tenofovir Alafenamide, GS-9620)]; Gilead Sciences [Hepatitis C (Ledipasvir/Sofosbuvir, Sofosbuvir/Velpatasvir/Voxilaprevir)]; Intercept Pharmaceuticals [Nonalcoholic Steatohepatitis (Obeticholic Acid)]; Intercept Pharmaceuticals [Primary Biliary Cirrhosis (Obeticholic Acid)]; Intercept Pharmaceuticals, Inc. [Primary Sclerosing Cholangitis (Obeticholic Acid)]; Merck [Hepatitis C (elbasvir/grazoprevir, Uprifosbuvir, Ruzasvir)] Speaking/Teaching: Gilead Sciences [Hepatitis B (Tenofovir/Tenofovir Alafenamide, GS-9620)]; Gilead Sciences [Hepatitis C (Ledipasvir/Sofosbuvir, Sofosbuvir/Velpatasvir/Voxilaprevir)]; Intercept Pharmaceuticals [Nonalcoholic Steatohepatitis (Obeticholic Acid)].

William M Grady, MD

Professor of Medicine

University of Washington and the Fred Hutchinson Cancer Research Center

Disclosure: Nothing to disclose

Norton J Greenberger, MD

Professor of Medicine (part-time)

Harvard Medical School

Disclosure: Nothing to disclose

Neil J Halin, DO, FSIR

Assistant Professor in Radiology

Tufts University School of Medicine

Disclosure: Nothing to disclose

Matthew J Hamilton, MD

Instructor in Medicine

Harvard Medical School

Disclosure: Grant/Research/Clinical Trial Support: Pfizer.

Karen Hardinger, PharmD, BCPS

Clinical Professor

University of Missouri-Kansas City

Disclosure: Nothing to disclose

Ikuo Hirano, MD

Associate Professor of Medicine, Gastroenterology Division

Northwestern University Feinberg School of Medicine

Disclosure: Consultant/Advisory Boards: Shire, Receptos, Regeneron, Adare [Eosinophilic esophagitis (Oral budesonide{Not approved or commercially available}, Anti IL13, Anti IL4/IL13, Fluticasone)].

Richard A Hodin, MD

Professor of Surgery

Harvard Medical School

Disclosure: Nothing to disclose

Michael Horowitz, MD, PhD

Professor of Medicine

The University of Adelaide

Disclosure: Grant/Research/Clinical Trial Support: TRACON Pharmaceuticals; Research support of a clinical trial.

Sergio Huerta, MD

Disclosure: Nothing to disclose

Thomas F Imperiale, MD

Professor of Medicine

Indiana University School of Medicine

Disclosure: Grant/Research/Clinical Trial Support: Grant support from Exact Sciences to Indiana University (for me to run its Longitudinal study).

Andreas M Kaiser, MD, FACS

Associate Professor of Clinical Colorectal Surgery

University of Southern California Keck School of Medicine

Disclosure: Consultant/Advisory Boards: Olympus, Inc.

Patrick S Kamath, MD

Professor of Medicine

Mayo Clinic College of Medicine

Disclosure: Nothing to disclose

Sunanda V Kane, MD, MSPH

Professor

Mayo Clinic College of Medicine

Disclosure: Grant/Research/Clinical Trial Support: UCB [IBD (Certolizumab)]. Consultant/Advisory Boards: AbbVie [IBD (Adalimumab)]; 11Health [IBD (Ostomy pouch sensor)]; Samsung Bioepis [Biosimilars for IBD]. Other Financial Interest: ABIM [Gastroenterology]; Arabella Associates [Sherman Prize for IBD].

Neil Kaplowitz, MD

AGA Peer Reviewer

Professor and Chief, GI/Liver

University of Southern California School of Medicine

Disclosure: Consultant/Advisory Boards: Acorda Therapeutics [Hepatotoxicity of drugs in development]; Astra Zeneca [ [Hepatotoxicity of drugs in development]; F. Hoffman-La Roche, Ltd [Hepatotoxicity of drugs in development]; Glaxo Smith Kline [Hepatotoxicity of drugs in development]; Novartis Pharma [Hepatotoxicity of drugs in development]; Pfizer, Inc [Hepatotoxicity of drugs in development]. -

VK Kapoor, FACS, FRCS, FACG

Professor, SGPGIMS Lucknow, India

Zayed Military Hospital, Abu Dhabi UAE

Disclosure: Nothing to disclose

Philip O Katz, MD

Director Motility Laboratories

Jay Monahan Center

Weill Cornell Medicine

Disclosure: Consultant/Advisory Boards: Torax [GERD (Magnetic Sphincter Augmentation)].

Jiwon Kim, PharmD, BCPS, FCSHP

Assistant Professor of Clinical Pharmacy

University of Southern California School of Pharmacy

Disclosure: Nothing to disclose

Joshua R Korzenik, MD

AGA Peer Reviewer

Assistant Professor of Medicine

Harvard Medical School

Disclosure: Grant/Research/Clinical Trial Support: AbbVie; Tacked; Transparency; Pfizer (IBD). Consultant/Advisory Boards: Genentech (DSMB [Etrolizumab]). Patent Holder: Coronary concepts (bowel prep). Equity Ownership/Stock Options: Coronary concepts (bowel prep).

Young-Mee Lee, MD

AGA Peer Reviewer

Adjunct Associate Professor of Medicine

Tufts University School of Medicine

Cambridge University Addenbrookes Hospital, Cambridge UK.

Disclosure: Grant/Research/Clinical Trial Support (Spouse): Cancer Research UK Grant [Molecular basis of immunity and immune based diseases; Immunology]; AstraZeneca [Molecular basis of immunity and immune based diseases; Immunology]; NIH grant [Molecular basis of immunity and immune based diseases; Immunology]. Consultant/Advisory Boards (Spouse): Bristows Law Firm [Patent issues – Immunology]; Freshfields Bruckhaus Deringer LLP [Patient issues - Immunology]; Irell and Manella LLP [Patent issues-immunology]. Equity Ownership/Stock Options (Spouse): Immune Signal Ltd, President Biotech [Immunology (immune modulators)]; Immune Ventures, President Biotech [Immunology (immune modulators)].

Cynthia Levy, MD

Associate Professor of Medicine

University of Miami School of Medicine

Disclosure: Grant/Research/Clinical Trial Support: Gilead [PSC (Simtuzumab)]; Intercept [PBC and PSC (Obeticholic acid)]; Novartis [PBC (LJN452)]; Tobira [PSC (Cenicriviroc)]; NGM [PSC (NGM282)]; CymaBay [PBC (MBX-8025)]; Gilead [PBC and PSC (GS9674)]; . Consultant/Advisory Boards: Intercept [PBC (Obeticholic acid)]; Novartis [PBC]. Other Financial Interest: Editorial Board of Liver Transplantation.

Noralane M Lindor, MD

Professor of Medical Genetics

Mayo Clinic School of Medicine

Disclosure: Nothing to disclose

Uma Mahadevan, MD

Professor of Medicine

University of California, San Francisco

Disclosure: Grant/Research/Clinical Trial Support: Prometheus; Prometheus; Takeda [IBD (Serum assay, vedolizumab)]. Consultant/Advisory Boards: Celgene; Janssen; Abbvie; UCB; Genetech; Pfizer; BMS; vedolizumab [IBD (Mongersen, Inflixlimab, adalimumab, certolizumab, tofacitinib)].

John Marshall, MD

Professor of Medicine

University of Missouri School of Medicine

Disclosure: Nothing to disclose

Paul Martin, MD, FACP

AGA Peer Reviewer

Professor of Medicine

University of Miami Miller School of Medicine

Disclosure: Grant/Research/Clinical Trial Support: Gilead; Merek & Co., Inc; Bristol-Myers Squibb.; Abbvie Consultant/Advisory Boards: Bristol-Myers Squibb; Abbvie.

Kenneth EL McColl, MD, FRCP, FMedSci

AGA Peer Reviewer

Professor, Head of Division of Gastroenterology

University of Glasgow

Disclosure: Consultant/Advisory Boards: AstraZeneca [Gastroesophageal disease (Esomeprazole, omeprazole)].

Joseph Misdraji, MD

Associate Pathologist

Massachusetts General Hospital

Harvard Medical School

Disclosure: Nothing to disclose

Kevin D Mullen, MD

Professor of Medicine

Case Western Reserve University

Disclosure: Speaker's Bureau: Salix/Valeant Pharmaceuticals [Hepatic encephalopathy (Rifaximin)].

Anil B Nagar, MD

Associate Professor, Department of Internal Medicine

Yale University School of Medicine

Disclosure: Nothing to disclose

Jeremy Nightingale, MD, FRCP

Consultant Gastroenterologist

St. Mark's Hospital, Harrow, UK

Disclosure: Nothing to disclose

Rose O'Flynn, PharmD, BCPS

Clinical Coordinator and Residency Program Director

Philadelphia VA Medical Center

Disclosure: Nothing to disclose

Bergein F Overholt, MD

Medical Director, Laser Center

Thompson Cancer Survival Center, Knoxville, TN

Disclosure: Nothing to disclose

Henry P Parkman, MD

Professor of Medicine

Temple University School of Medicine

Disclosure: Grant/Research/Clinical Trial Support: NIH; Vanda; AstraZeneca. Consultant/Advisory Boards: Takeda.

Marcos C Pedrosa, MD, MPH

Associate Professor of Medicine

Boston University School of Medicine

Disclosure: Employment: Novartis [Hepatology] - No relevant conflict on topic. Equity Ownership/Stock Options: Novartis [restricted stock units as part of compensation].

Harry Pothoulakis, MD

Professor of Medicine

Pathology and Laboratory Medicine

David Geffen School of Medicine at UCLA

Disclosure: Nothing to disclose

Eamonn Quigley, MD

Chief of Gastroenterology

The Methodist Hospital, Houston, Texas

Disclosure: Grant/Research/Clinical Trial Support: Vibrant; Rhythm; Theravance [Constipation, gastroparesis]. Speaker's Bureau: Astra Zeneca; Ironwood; Procter and Gamble [Constipation, IBS (Naloxegol, linaclotide, probiotic supplement)]. Consultant/Advisory Boards: Salix; Synergy; Commonwealth; Biocodex; Vibrant; Alimentary Health [IBS (Rifaximin, probiotic supplement)]; Allergan [IBS, constipation]. Equity Ownership/Stock Options: Alimentary Health [Microbiome, probiotics].

Laura Raffals, MD

Instructor of Medicine

Mayo Clinic

Disclosure: Nothing to disclose

Satish SC Rao, MD, PhD, FRCP

Chief, Gastroenterology/Hepatology

Georgia Regents University

Disclosure: Grant/Research/Clinical Trial Support: Sun Sweet Corporation [Constipation (Fiber supplement)]; Forest Laboratories [IBS (Linaclotide)]; Synergy Pharmaceuticals [IBS and constipation (Plecanatide)]; Salix Pharmaceuticals [IBS (Rifaximin)]; Ventrus Biosciences [Anal fissure (Diltiazem cream)]; Covidien [Gastroparesis (Capsule)]; Vibrant [Constipation [vibrating peristaltic capsule)].Consultant/Advisory Boards: Forest Laboratories [Constipation (Linaclotide)]; Hollister [Fecal incontinence (Bag)]; Ironwood Pharmaceuticals [Constipation (Linaclotide)]; Sucampo Pharmaceuticals [Constipation and IB (Lubiprostone)]; In Control Medical [Biofeedback (Biofeedback device)]; Vibrant [Constipation [vibrating peristaltic capsule)]. Data Monitoring Board: American Medical Systems [Fecal incontinence (Implantable device)].

K Rajender Reddy, MD

Ruimy Family President's Distinguished Professor of Medicine

Professor of Medicine in Surgery

Director of Hepatology

Director, Viral Hepatitis Center

Medical Director of Liver Transplantation

University of Pennsylvania School of Medicine

Disclosure: Grant/Research/Clinical Trial Support (money paid to the University of Pennsylvania): Abbvie; BMS; Gilead; Janssen; Merck [Hepatitis C]. Consultant/Advisory Boards: Abbvie; BMS; Gilead; Janssen; Merck (Hepatitis C).

Miguel Regueiro, MD, AGAF, FACG, FACP

Associate Professor of Medicine

University of Pittsburgh

Disclosure: Consultant/Advisory Boards: Janssen [Crohn's disease treatment (infliximab)]; AbbVie [Crohn's disease treatment (adalimumab)]; UCB [Crohn's disease treatment (certolizumab)]; Takeda [Crohn's disease treatment (vedolizumab)]; Pfizer [IBD (tofacitinib)]; Celgene [Crohn's disease treatment (SMAD-7)]; Miraca [Crohn's disease treatment (infliximab therapeutic monitoring)].

Anna E Rutherford, MD, MPH

Instructor in Medicine

Harvard Medical School

Disclosure: Nothing to disclose

John D Ryan, MBBS, MRCPI, PhD

Academic Clinical Lecturer in Gastroenterology

University of Oxford

Disclosure: Nothing to disclose

Arturo P Saavedra, MD, PhD, MBA

Assistant Professor in Dermatology, Dermatopathology, and Medicine

Brigham and Women’s Hospital, Harvard Medical School

Disclosure: Nothing to disclose

George Sachs, MD

Professor of Medicine

David Geffen School of Medicine at UCLA

Disclosure: Nothing to disclose

John R Saltzman, MD, FACP, FACG, FASGE, AGAF

Section Editor — Therapeutic and Diagnostic Endoscopy

Professor of Medicine

Harvard Medical School

Disclosure: Nothing to disclose

Shiv Sarin, MD

AGA Peer Reviewer

Senior Professor and Head

Department of Hepatology, Institute of Liver and Biliary Sciences

New Delhi, India

Disclosure: Nothing to disclose

Michael Saunders, MD

Clinical Assistant Professor

University of Washington Medical Center

Disclosure: Nothing to disclose

Thomas J Savides, MD

Professor of Clinical Medicine

University of California, San Diego, CA

Disclosure: Grant/Research/Clinical Trial Support: Boston Scientific [GI Endoscopy]. Speaker’s Bureau: Olympus [GI Endoscopy].

Robert Schapiro, MD

AGA Peer Reviewer

Associate Clinical Professor of Medicine

Harvard Medical School

Disclosure: Nothing to disclose

Peter Schemmer, MD

Department of General Surgery

Ruprecht-Karls University of Heidelberg

Disclosure: Nothing to disclose

Detlef Schuppan, MD, PhD

Professor of Medicine, Harvard Medical School

Institute for Translational Immunology

Research Center for Immunotherapy (FZI), University Medical Center, Johannes Gutenberg University, Mainz, Germany, Division of Gastroenterology

Disclosure: Patent Holder: Eurospital [Celiac disease (TG2-antibody)]; Consultant/Advisory Boards: Takeda [Celiac disease (Celiac disease drug development)].

Neil Stollman, MD, FACP, FACG, AGAF

Associate Clinical Professor of Medicine

University of California San Francisco

Disclosure: Nothing to disclose

Mario Strazzabosco, MD, PhD

Professor of Medicine

Yale University School of Medicine

Disclosure: Nothing to disclose

Pavel Strnad, MD

Department of Internal Medicine I,

University Medical Center Ulm, Germany

Disclosure: Nothing to disclose

Haruhiko Sugimura, MD, PhD

Hamamatsu University School of Medicine

Disclosure: Nothing to disclose

W Brian Sweeney, MD

University of Massachusetts Medical School

Disclosure: Nothing to disclose

Ali Tavakkoli, MD

Associate Professor of Surgery

Harvard Medical School

Disclosure: Nothing to disclose

Bruce W Trotman, MD

Digestive Disease Specialists of Manatee

Manatee Memorial Hospital

Disclosure: Nothing to disclose

Nimish B Vakil, MD, AGAF, FACP, FACG, FASGE

Clinical Professor of Medicine

University of Wisconsin School of Medicine and Public Health

Disclosure: Consultant/Advisory Boards: Ironwood [IBS (Linaclotide)]; Allergan [IBS (Linaclotide, eluxadoline)]; Yuhan [Dyspepsia].

John J Vargo, MD

Department of Gastroenterology

Cleveland Clinic Foundation

Disclosure: Consultant/Advisory Boards: Paion Medical [Procedural sedation (Remimazolam)].

Michael B Wallace, MD, MPH

Professor of Medicine

Mayo Clinic, Jacksonville

Disclosure: Grant/Research/Clinical Trial Support: Boston Scientific [Fine-needle aspiration (FNA needles)]; NinePoint Medical [Optical frequency domain imaging (OFDI systems)]; Cosmo Pharma [Chromoendoscopy (Chromoendoscopy solutions)]; Medtronic [Pancreas cancer (EUS guided needle biopsy device)]. Consultant/Advisory Boards: Olympus [Wide-angle endoscopes (Endoscopes)].

Rebecca G Wells, MD

Assistant Professor of Medicine

University of Pennsylvania School of Medicine

Disclosure: Consultant/Advisory Boards: Dicerna [makes siRNA to be potentially used as therapeutics for liver fibrosis. I receive an honorarium for providing advice on potential targets].

Yu-Xiao Yang, MD, MSCE, FACP

Assistant Professor of Medicine and Epidemiology

University of Pennsylvania School of Medicine

Disclosure: Nothing to disclose

Tony E Yusuf, MD

Assistant Professor of Medicine

SUNY Downstate College of Medicine

Disclosure: Nothing to disclose